EUVIMEDEUVIMED entdecken
Crossref

Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies

Bohong Gao, Zhihua Yin, Yue Zhang

Current Rheumatology Research · 2024

DOI: 10.46439/rheumatology.4.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Rheumatology Research, 2024. Verfasst von Bohong Gao und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arthritis remains a common and debilitating disease affecting millions of people worldwide. Osteoarthritis (OA) and rheumatoid arthritis (RA) are among the most common forms of this chronic, degenerative disease, which is moving toward precision medicine.

Zitieren

APA

Gao, B., Yin, Z., & Zhang, Y. (2024). Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies. Current Rheumatology Research. https://doi.org/10.46439/rheumatology.4.025

Vancouver

Gao B, Yin Z, Zhang Y. Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies. Current Rheumatology Research. 2024. doi:10.46439/rheumatology.4.025

BibTeX
@article{Gao2024,
  author = {Gao, Bohong and Yin, Zhihua and Zhang, Yue},
  title = {Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies},
  journal = {Current Rheumatology Research},
  year = {2024},
  doi = {10.46439/rheumatology.4.025}
}
Kostenlos starten →